High Content Screening of a Kinase-Focused Library Reveals Compounds Broadly-Active against Dengue Viruses

Dengue virus is a mosquito-borne flavivirus that has a large impact in global health. It is considered as one of the medically important arboviruses, and developing a preventive or therapeutic solution remains a top priority in the medical and scientific community. Drug discovery programs for potential dengue antivirals have increased dramatically over the last decade, largely in part to the introduction of high-throughput assays. In this study, we have developed an image-based dengue high-throughput/high-content assay (HT/HCA) using an innovative computer vision approach to screen a kinase-focused library for anti-dengue compounds. Using this dengue HT/HCA, we identified a group of compounds with a 4-(1-aminoethyl)-N-methylthiazol-2-amine as a common core structure that inhibits dengue viral infection in a human liver-derived cell line (Huh-7.5 cells). Compounds CND1201, CND1203 and CND1243 exhibited strong antiviral activities against all four dengue serotypes. Plaque reduction and time-of-addition assays suggests that these compounds interfere with the late stage of viral infection cycle. These findings demonstrate that our image-based dengue HT/HCA is a reliable tool that can be used to screen various chemical libraries for potential dengue antiviral candidates. © 2013 Cruz et al.

Identification of Novel Compounds Inhibiting Chikungunya Virus-Induced Cell Death by High Throughput Screening of a Kinase Inhibitor Library

Chikungunya virus (CHIKV) is a mosquito-borne arthrogenic alphavirus that causes acute febrile illness in humans accompanied by joint pains and in many cases, persistent arthralgia lasting weeks to years. The re-emergence of CHIKV has resulted in numerous outbreaks in the eastern hemisphere, and threatens to expand in the foreseeable future. Unfortunately, no effective treatment is currently available. The present study reports the use of resazurin in a cell-based high-throughput assay, and an image-based high-content assay to identify and characterize inhibitors of CHIKV-infection in vitro. CHIKV is a highly cytopathic virus that rapidly kills infected cells. Thus, cell viability of HuH-7 cells infected with CHIKV in the presence of compounds was determined by measuring metabolic reduction of resazurin to identify inhibitors of CHIKV-associated cell death. A kinase inhibitor library of 4,000 compounds was screened against CHIKV infection of HuH-7 cells using the resazurin reduction assay, and the cell toxicity was also measured in non-infected cells. Seventy-two compounds showing >= 50% inhibition property against CHIKV at 10 mu M were selected as primary hits. Four compounds having a benzofuran core scaffold (CND0335, CND0364, CND0366 and CND0415), one pyrrolopyridine (CND0545) and one thiazol-carboxamide (CND3514) inhibited CHIKV-associated cell death in a dose-dependent manner, with EC50 values between 2.2 mu M and 7.1 mu M. Based on image analysis, these 6 hit compounds did not inhibit CHIKV replication in the host cell. However, CHIKV-infected cells manifested less prominent apoptotic blebs typical of CHIKV cytopathic effect compared with the control infection. Moreover, treatment with these compounds reduced viral titers in the medium of CHIKV-infected cells by up to 100-fold. In conclusion, this cell-based high-throughput screening assay using resazurin, combined with the image-based high content assay approach identified compounds against CHIKV having a novel antiviral activity -inhibition of virus-induced CPE - likely by targeting kinases involved in apoptosis.

Concurrent dengue and malaria in the Amazon region

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Estudo de arboviroses em pacientes positivos para malária da região Amazônica

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Estudo de arboviroses em doadores de sangue na região Amazônica e em uma cidade do interior de São Paulo

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Diagnóstico molecular de arboviroses brasileiras em soros de pacientes com doença febril aguda

Pós-graduação em Microbiologia - IBILCE

Avaliação dos componentes de óleos essenciais 1,8-cineol, β-cariofileno e α-humuleno como possíveis repelentes para Aedes (Stegomyia) aegypti (Diptera: Culicidae)

Aedes aegypti, mosquito da família Culicidae responsável pela transmissão dos vírus da dengue, da febre amarela urbana e da febre chikungunya, apresenta grande proliferação em áreas urbanas das regiões tropicais e subtropicais, além de representar um fator de incômodo por causar alergias devido à inoculação dos componentes salivares durante o processo do repasto sanguíneo. Como forma de evitar os problemas causados por eles, o repelente mais usado e registrado comercialmente desde 1957 é o DEET (N,N-dietil-3-metilbenzamida ou N,N-dietil-meta-toluamida), que apesar de apresentar eficácia comprovada possui determinada toxicidade quando utilizado por crianças e por mulheres grávidas ou lactantes. Atualmente, grande parte dos estudos sobre novas substâncias repelentes envolvem óleos essenciais de plantas, principalmente por serem atóxicos, biodegradáveis, possuírem um preço mais acessível e uma ampla atividade contra diferentes espécies de mosquitos. Os terpenos 1,8-cineol, β-cariofileno e α-humuleno podem ser encontrados em óleos essenciais de uma grande variedade de plantas e apesar de dados da literatura mostrarem uma eficácia dessas substâncias como repelentes para outras espécies de insetos, até o presente momento não existem estudos que relacionam porcentagem de repelência ao longo do tempo para avaliar o potencial de repelência das mesmas para culicídeos.O presente estudo avaliou tais substâncias como possíveis repelentes para A. aegypti, utilizando o DEET como controle positivo. Para avaliar a eficácia do β-cariofileno foi utilizada a BG-cage, uma gaiola desenvolvida especificamente para testes de repelência onde o voluntário expõe um braço sob uma abertura coberta por uma tela onde os mosquitos pousam, mas não picam. Os testes foram repetidos a cada 30 minutos após a aplicação do produto por um tempo máximo de duas horas (seguindo a recomendação de reaplicação do produto comercial ...

Rhamnolipids: solution against Aedes aegypti?

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)